Dr Kathryn Wicht

Kathryn’s work is currently focused on the mechanisms of action and resistance of Plasmodium kinase and hemozoin inhibitors, in development as potential novel antimalarials. Her goals are to build platforms at UCT for studying drug targets and resistance of African-relevant malaria parasite strains, as well as performing genome editing of Plasmodium parasites. She is part of the academic Plasmodium Cell Culture Laboratory.